Jonathan J. Wilson

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

I. F. Tannock, David Osoba, Martin R. Stockler et al. · Journal of Clinical Oncology · 1996 · 1.6K citations

Medicine, Oncology, Pharmacotherapy +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.

D.J. Stewart, William K. Evans, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1997 · 50 citations

Medicine, Oncology, Pharmacology +15

Fibrinolytic therapy for idiopathic subclavian-axillary vein thrombosis

Jonathan J. Wilson, Catherine Zahn, Harold F. Newman · The American Journal of Surgery · 1990 · 36 citations

Medicine, Pharmacotherapy, Surgery +13

Subclavian-axillary vein thrombosis: successful treatment with streptokinase.

Jonathan J. Wilson, D. M. LESK, Harold F. Newman · PubMed · 1984 · 17 citations

Medicine, Hematology, Surgery +6